首页> 外国专利> Synergistic effect of amlodipine and atorvastatin or Atorvastatin metabolite as a basis for Combination Therapy

Synergistic effect of amlodipine and atorvastatin or Atorvastatin metabolite as a basis for Combination Therapy

机译:氨氯地平与阿托伐他汀或阿托伐他汀代谢物的协同作用作为联合治疗的基础

摘要

The combination of Amlodipine with either Atorvastatin or Atorvastatin metabolite shows a synergistic Antioxidant effect on Lipid peroxidation of Human low density lipoproteins and VesicHanging Membrane enriched with polyunsaturated fatty acids.Inhibition of Oxy radical damage was observed For This combination of drugs at Therapeutic levels in a way that cannot be reproduced by the combination of Amlodipine with statins or otherNatural Antioxidant, Vitamin E.The basis for this potent activity is attributed to the Chemical structures of these compounds and their molecular Interactions with the Molecules of fosdolu00edpidos,As determined by x-ray diffraction analysis.This combination Therapy may be used to treat cardiovascular diseases, especially coronary artery disease;Increased Resistance of low density lipoproteins and vascular Cell membranbas against oxidative modification.
机译:氨氯地平与阿托伐他汀或阿托伐他汀代谢物的组合对人低密度脂蛋白和富含多不饱和脂肪酸的VesicHanging膜的脂质过氧化具有协同抗氧化作用。氨氯地平与他汀类药物或其他天然抗氧化剂维生素E不能重现。这种有效活性的基础归因于这些化合物的化学结构及其与fosdol u00edpidos分子的分子相互作用,由x-射线衍射分析。该组合疗法可用于治疗心血管疾病,尤其是冠状动脉疾病;低密度脂蛋白和血管细胞膜对氧化修饰的抵抗力增强。

著录项

  • 公开/公告号ECSP003442A

    专利类型

  • 公开/公告日2000-08-18

    原文格式PDF

  • 申请/专利权人 MASON PRESTON R.;

    申请/专利号EC2000SP03442

  • 发明设计人 MASON PRESTON R.;

    申请日2000-04-27

  • 分类号C07D401/12;A61K31/40;A61K31/43;

  • 国家 EC

  • 入库时间 2022-08-22 01:56:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号